|
|
home > news |
 |
 |
INDUSTRY NEWS AND PRESS RELEASES |
 |
|
World-class multidisciplinary partnership to take science one step closer to building fully functional organs at lightning speed
In the European project ENLIGHT, researchers from academic centers and
leading industries across Europe are joining forces to develop a living
model of the pancreas to enable better testing of diabetes medication. More>> |
|
|
SPT Labtech acquires BioMicroLab
Deal strategically expands SPT Labtech’s offering in sample management for life sciences
SPT Labtech, a global leader in the design and development of automated
instrumentation and consumables for life science applications, announces
the acquisition of BioMicroLab, a robotics automation provider for life
science laboratories. More>> |
|
|
NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials
NovalGen Ltd. (“NovalGen”), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (“HALIX”), a contract development and manufacturing organisation, today
announced a strategic partnership. Within the scope of this
partnership, HALIX will provide manufacturing of clinical supply of
NovalGen’s therapies. More>> |
|
|
Catalent Announces Commercial Supply Agreement with Aurinia Pharmaceuticals for Newly-Approved LUPKYNIST Softgels
Catalent, the leading global provider of advanced delivery technologies,
development, and manufacturing solutions for drugs, biologics, cell and
gene therapies, and consumer health products, today announced that it
recently signed a multi-year commercial supply agreement with Aurinia
Pharmaceuticals. More>> |
|
|
PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19
PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the initiation of
the second stage of the FITE19 clinical trial to assess PTC299 in
COVID-19 patients. PTC299 is an oral investigational drug with a novel
dual mechanism of action that has the potential to inhibit viral
replication and attenuate the uncontrolled inflammatory response that
ensues after infection. More>> |
|
|
Theravectys Announces $20M Funding Round
Funding to drive Phase 1 and 1-2 Clinical Trials for COVID-19, HPV induced cancers and HBV Vaccine Candidates
THERAVECTYS,
the world leading pioneer in lentiviral vector technology, announced
today a fully subscribed $20M funding round. This funding will be used
to progress the Theravectys pipeline by driving several vaccine
candidates, including their COVID vaccine, into phase 1 and 1-2 clinical
trials. More>> |
|
|
Vetter continues its successful performance at the 2021 CMO Leadership Awards
Ravensburg, Germany, February 18, 2021 – Vetter, a globally
operating Contract Development and Manufacturing Organization (CDMO),
was granted the 2021 CMO Leadership Awards in five core categories –
quality, expertise, compatibility, capabilities, and service. The award,
now in its tenth year, was given by the leading trade press
publication, Life Science Leader. Vetter was also the recipient of the
award in a variety of categories in previous years. More>> |
|
|
Sonoco ThermoSafe Celebrates First Pegasus ULD® Uplift on AirBridgeCargo Airlines, Releases Case Study
ARLINGTON HEIGHTS, Ill., Feb. 08, 2021 -- Sonoco ThermoSafe, a
unit of Sonoco (NYSE:SON) and the leading global provider of temperature
assurance packaging for life sciences and healthcare, and
AirBridgeCargo Airlines, an all-cargo carrier within the Volga-Dnepr
Group, have successfully conducted a test shipment with ThermoSafe’s new
Pegasus ULD®, the world’s first passive bulk temperature controlled
container for pharmaceutical use that is an approved unit load device. More>> |
|
|
Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis
Crystal Lake, Illinois, February 16, 2021 - AptarGroup, Inc.
(NYSE: ATR), a global leader in drug delivery, consumer product
dispensing and active packaging solutions, announced that its
Activ-Film™ technology was selected to protect a new SARS Rapid Antigen
test for COVID-19 that recently received Emergency Use Authorization
(EUA) from the U.S. Food and Drug Administration (FDA). More>> |
|
|
Medidata Launches Sensor Cloud, Ushering in Next Generation Solution for Connected Devices and Wearable Sensors in Clinical Trials
Unified solution simplifies and expedites sensor integration, data ingestion and analysis, and digital biomarker discovery
New technology will generate intelligent insights and help improve clinical outcomes More>> |
|
|
|
 |
|
|
 |
News and Press Releases |
 |
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
Companies enter into a collaboration and services agreement / Bayer to support CureVac in numerous areas, including development and supply of CVnCoV / CureVac benefits from Bayer´s expertise and established infrastructure / Plan to facilitate the supply of several hundred million doses
More info >> |
|
 |
White Papers |
 |
Inhaler Adherence: Exploring Key Factors
Aptar Pharma
Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >> |
|
 |
Industry Events |
 |
DIA Europe 2021
15-19 March 2021, VIRTUAL CONFERENCE
DIA Europe is the must-attend event for all life science professionals
working in drug development, from discovery to marketed use. It
encourages open collaboration by bringing together representatives from
the entire spectrum of the life science landscape and facilitating
crucial discussions across several topic tracks: Clinical Development,
Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy,
and many more.
More info >> |
|
|